ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,793, issued on April 15, was assigned to Impax Laboratories LLC (Bridgewater, N.J.).

"Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof" was invented by Ann Hsu (Hayward, Calif.), Liang Dong (Hayward, Calif.), Amy Ding (Hayward, Calif.) and Suneel Gupta (Hayward, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an oral solid formulation comprising (a) one or more controlled release components comprising a core comprising levodopa, esters or salts thereof and wherein the one or more controlled release components; and (b) one or more immediate release components comprising l...